Day: January 21, 2021

ROCKAWAY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Health Improvement Scotland (“HIS”) has published a Scottish Health Technology Group (“SHTG”) adaptation for NHS Scotland on the use of gammaCore for cluster headache. The SHTG publication is based on guidance produced in 2019 by the U.K. National Institute for Health and Care Excellence (“NICE”), which states that gammaCore, when used alongside standard of care, can reduce the frequency and intensity of cluster headache attacks, leading to significant quality of life benefits for people living with this condition and can save an average of £450 per patient in the first year of treatment through a reduction in acute rescue medication use, and with electroCore offering no-cost...

BOTHELL, Wash., Jan. 21, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, the SARS-CoV-2 virus, hepatitis C viruses and noroviruses, provides the following summary of today’s upcoming presentation by Cocrystal President Sam Lee, Ph.D. at the virtual 3rd Annual reimagine Health Research Symposium, University of Arizona College of Medicine. A live webcast of Dr. Lee’s presentation, titled “Application of Structure-Based Drug Design Platform Technology for Developing Broad Spectrum, COVID-19, Influenza, and HCV Antivirals,” will be available at 9:50 a.m. Pacific time (12:50 p.m. Eastern time) by registering here. Dr. Lee’s presentation...

Patients with stable symptoms of schizophrenia were switched from previous antipsychotic medications with no dose titration to CAPLYTA 42 mg for a 6-week treatment duration, then switched back to previous or another approved antipsychotic.In patients with stable symptoms of schizophrenia, CAPLYTA was well-tolerated with low rates of metabolic and extrapyramidal symptoms (EPS) adverse events; schizophrenia symptoms remained stable and did not worsen from baseline.NEW YORK, Jan. 21, 2021 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the publication of results from the CAPLYTA clinical trial (ITI-007-303) in adult patients with schizophrenia. The article, “Safety...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated November 9, 2020 to its final short form base shelf prospectus for the Province of Quebec and its amended and restated final short form base shelf prospectus for each of the Provinces of Canada except Quebec, each dated October 27, 2020.VANCOUVER, British Columbia, Jan. 21, 2021 (GLOBE NEWSWIRE) — Westport Fuel Systems Inc. (“Westport Fuel Systems”) (TSX:WPRT / Nasdaq:WPRT) today announced it has agreed to commence a research project with Scania to apply its HPDI 2.0TM fuel system with hydrogen to the latest Scania commercial vehicle engine. Preliminary test results are expected in the second half of 2021.“Our specialty is working with gaseous fuels. Hydrogen use in an internal combustion engine with our HPDI fuel...

TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) — Unifor and Aleafia Health Inc. (TSX: AH, OTC: ALEAF), have entered into an exclusive 10-year agreement to support union members, retirees and their eligible dependents who receive medical cannabis insurance coverage through Unifor’s collective bargaining agreements.“Unifor members across the country deserve access to the benefits of medical cannabis coverage through their benefits. As a union we will support our local bargaining committees to add this coverage where possible,” said Jerry Dias, Unifor National President.The agreement supports a historic breakthrough in access to legal cannabis in Canada.Aleafia brings unique national scale, organization and expertise to provide union members, retirees and their eligible dependents with access to medical cannabis product insurance...

BRØNDBYERNES I.F. FODBOLD A/SCVR-nr. 83 93 34 10Brøndby, den 21.januar2021SELSKABSMEDDELELSE NR. 01/2021Brøndbyernes IF Fodbold A/S – Kontraktforlængelse med cheftræner Niels FrederiksenBrøndby IF har i dag indgået aftale om kontraktforlængelse med Niels Frederiksen, hvis kontrakt stod til udløb 30. juni 2021. Den nye kontrakt har udløb 30. juni 2023.Med venlig hilsenBrøndby IFCarsten V. JensenFodbolddirektørInformationYderligere information om denne meddelelse kan fås hos fodbolddirektør Carsten V. Jensen på telefon 43 63 08 10.Vedhæftet filFBM nr 1 2021 Brondby IF – Kontraktforlaengelse med cheftraener Niels Frederiksen

HOUSTON, Jan. 21, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that it has received a letter from the Nasdaq Listing Qualifications staff notifying the Company that it has regained compliance with Nasdaq’s Listing Rule 5550(a)(2) pertaining to the minimum bid price requirement for continued listing on the Nasdaq Capital Market.About Salarius PharmaceuticalsSalarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing cancer therapies for patients in need of new treatment options. Salarius’ lead candidate, seclidemstat, is being studied as a potential treatment for pediatric cancers, solid tumors and other cancers...

CALGARY, Alberta, Jan. 21, 2021 (GLOBE NEWSWIRE) — Quorum Information Technologies Inc. (TSX Venture: QIS) (Quorum) announced today that it is launching a Windows Virtual Desktop pilot built on Microsoft Azure. After the pilot, Quorum will be able to deploy its XSellerator Dealership Management System (DMS) to automotive dealership customers leveraging the Microsoft Azure cloud platform, eliminating the need for an on-premise server or a Quorum hosted solution.“As a long-standing Microsoft gold partner, we are excited with the opportunity to pilot XSellerator as a cloud-based solution on Microsoft Azure,” said Maury Marks, President and CEO, Quorum. “With over 10,000 users, XSellerator is an Enterprise Resource Planning (ERP) system (or DMS) for automotive dealerships. Quorum is continuously working to reduce the deployment cost...

TARRYTOWN, NY, Jan. 21, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Nightfood, Inc. (OTCQB: NGTF), the company pioneering the category of “sleep-friendly” nutrition and snacking, today announced that founder and CEO Sean Folkson has extended his existing lock-up agreement for an additional twelve months.This information was first made public via an 8K filing on Wednesday, January 20, 2021.Folkson has not disposed of any shares in any way since November of 2015.  He has increased his position during that time by purchasing 400,000 shares through the exercise of warrants at a $.30 strike price, as well as through recent purchasing of shares in the open market. Folkson’s previous Lock-Up Agreement was set to expire On February 4, 2021.  That agreement has now been extended an additional twelve months, through February 4, 2022. ...